Heteroaryl inhibitors of PDE4

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12264169
APP PUB NO 20230348501A1
SERIAL NO

18350452

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TETRA DISCOVERY PARTNERS LLC301 MICHIGAN STREET NE GRAND RAPIDS MI 49503

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campbell, Robert Niskayuna, US 124 4610
Gurney, Mark E Grand Rapids, US 88 598
Hagen, Timothy J Lisle, US 56 410
Mo, Xuesheng Naperville, US 10 71
Romero, Donna L Chesterfield, US 69 752
Vellekoop, A Samuel Altamont, US 9 64
Walker, Joel R Schenectady, US 36 125
Zhu, Lei Schenectady, US 374 2364

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 1, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 1, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 1, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00